RBC Bearings' fiscal first-quarter earnings and revenues top estimates as aerospace growth, VACCO and wider margins lift results.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
IDEX (IEX) just released second quarter and first half 2026 results, along with an update on its long running share repurchase program, giving investors fresh numbers to evaluate the stock. See our latest analysis for IDEX. Recent earnings and buyback news come as IDEX trades at US$230.45, with the share price up 28.7% year to date and a 1 year total shareholder return of 46.98%. This points to momentum building over the past year despite a modest pullback in the last trading day. If you are...
IDEX Corporation recently reported its second-quarter 2026 results, with sales rising to US$920.6 million from US$865.4 million and diluted EPS from continuing operations increasing to US$1.93 from US$1.74 a year earlier. Alongside higher earnings, IDEX continued to shrink its share count, having repurchased about 25.04% of its stock for roughly US$1.74 billion since 2008, which can amplify per-share metrics over time. With IDEX lifting full-year organic growth and adjusted EPS guidance,...
Manufacturing company IDEX (NYSE:IEX) announced better-than-expected revenue in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.
IDEX (NYSE:IEX) reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted
Moby summary of IDEX Corporation's Q2 2026 earnings call
IDEX Corp (IEX) reports robust Q2 performance with significant order growth and raises full-year financial outlook.
IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.
IDEX Corporation (NYSE:IEX) reported better-than-expected second-quarter earnings and revenue while raising its full-year guidance, sending the industrial technology company’s shares nearly 4% higher in premarket trading on Wednesday. Adjusted earnings came in at $2.
The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Idex (IEX) delivered earnings and revenue surprises of +10.48% and +2.01%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.
Manufacturing company IDEX (NYSE:IEX) will be reporting results this Wednesday before market hours. Here’s what investors should know.
IEX reports Q2 results on July 29, with revenue growth expected as Health & Science demand and acquisitions support sales despite cost pressures.
IDEX has risen 24.7% year to date, yet its valuation signals are split, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while earnings based multiples lean the other way. The 24.7% year to date gain suggests investors have been willing to pay a richer price for IDEX shares in a relatively short period. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the stock trades at about a 22.8% discount to projected cash flows, while market...
RBC Bearings (RBC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Idex (IEX) and Silgan Holdings (SLGN) have performed compared to their sector so far this year.
IDEX trades at $223.61 and has moved in lockstep with the market. Its shares have returned 13.5% over the last six months while the S&P 500 has gained 8.7%.
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
IDEX Corporation enters Q2 earnings with strong momentum, as Wall Street watches for another solid performance.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IDEX (NYSE:IEX) and the rest of the gas and liquid handling stocks fared in Q1.
Idex (IEX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ITT benefits from strong segment growth, acquisitions and shareholder returns, though rising costs and debt remain concerns.
Here is how Idex (IEX) and Watts Water (WTS) have performed compared to their sector so far this year.
If you are wondering whether IDEX at around US$225.96 is priced for quality or starting to look stretched, the starting point is to understand what the current valuation is really telling you. The stock has returned 0.3% over the past week, 7.2% over the past month, 26.2% year to date, and 30.7% over the last year, which puts recent moves firmly on the radar for investors reassessing upside and risk. Alongside these returns, investors have been reacting to ongoing updates around IDEX's...
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
ALLE's Americas strength, acquisitions and shareholder returns support growth, though international weakness and rising costs remain.
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.